| Authors: |
Bahlis N; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada., Facon T; CHU Lille, Service des Maladies du Sang, University of Lille, Lille, France., San-Miguel J; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC, Pamplona, Spain., Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Department of Medicine, Korea University, Seoul, South Korea., Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Perrot A; CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France., Manier S; Maladies du Sang, Centre Hospitalo-Universitaire, Lille, France., Chari A; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Raje N; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA., Orlowski RZ; Departments of Lymphoma & Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Goldschmidt H; Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Study Group, Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, Germany., Basu S; Royal Wolverhampton NHS Trust and University of Wolverhampton, Clinical Research Network West Midlands, NIHR, Wolverhampton, United Kingdom., Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mohty M; Hematology and Cellular Therapy Department of Saint-Antoine Hospital, Sorbonne University, Paris, France., Leleu X; CHU Poitiers, Hôpital la Milétrie, Poitiers, France., Plesner T; Department of Internal Medicine, Section of Hematology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark., Jakubowiak A; University of Chicago Medical Center, Chicago, IL., Cook G; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Quach H; Clinical Haematology Service, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia., Venner CP; Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.; BC Cancer - Vancouver Centre Group, Vancouver, BC, Canada., Cavo M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Ngo M; Cytel, Cambridge, MA., Bolyard K; Johnson & Johnson, Raritan, NJ., Carson R; Johnson & Johnson, Spring House, PA., Borgsten F; Johnson & Johnson, Raritan, NJ., Mateos MV; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain., Kumar SK; Department of Hematology, Mayo Clinic, Rochester, MN. |
